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Abstract
Background: Primary cardiac tumors are rare and myxoma constitutes the majority. The present study summarizes
our 30-year clinical outcomes of surgical myxoma resection.
Methods: Between January 1986 and December 2015, 93 patients (30 men, 63 women; mean age, 54.7 ± 16.6 years)
underwent surgical myxoma resection. The most common origin site was the left atrium. Surgery was performed via a
biatrial approach in 74.2%, atrial septotomy through right atriotomy in 17.2%, and left atriotomy only in 8.6%. Mean
myxoma size based on longest length was 4.73 ± 1.92 cm (range, 1.2–11.0 cm).
Results: The mean follow-up duration was 9.9 ± 7.8 years (range, 0–29 years). In-hospital mortality was 3.2%. The most
common postoperative complication was atrial fibrillation (4.3%). The 5-, 10-, and 30-year survival rates were 92.9%, 87.
2%, and 75.5%, respectively. Recurrence occurred in two patients (2.1%), which were detected at 20 and 79 months
after the first surgery, respectively.
Conclusions: Long-term survival after myxoma resection was excellent and recurrence was rare. Based on our
experience, surgical method did not affect the outcome.
Keywords: Myxoma, Benign cardiac tumor
Background
Primary cardiac tumors are rare and approximately 70%
are benign. Myxoma is the only relatively common
primary heart neoplasm [1, 2], which is often found on
2-dimensional (2D) echocardiography. Myxoma occurs
in all ages and is 2 to 3 times more common in women
than in men. It can cause mild constitutional symptoms,
such as fever, weight loss, myalgia, or arthralgia, to ser-
ious hemodynamic derangement, depending on its loca-
tion and size, which can lead to disastrous embolic
symptoms. Therefore, if possible, prompt surgical resec-
tion is recommended.
The objective of this study was to assess our long-
term clinical outcomes of intracardiac myxoma resection
in a consecutive series of 93 patients.
Methods
From January 1986 to December 2015, 93 patients with
cardiac myxoma underwent surgery at our institution.
Myxoma was 2 times more common in women (63
patients, 67.7%) than in men (30 patients, 32.3%), and
the mean age of the patients was 54.7 ± 16.6 years
(range, 1–78 years).
The origin site of the tumor was the left atrium (LA) in
86 patients (92.5%), right atrium in 4 (4.3%), and left ven-
tricle in 2 (2.2%). Multiple myxomas in both atria and the
right ventricle were present in one patient (1.1%); his fam-
ily history of myxoma was not identified. Among the
tumors originating in the LA, the most common implant
site was the fossa ovalis (76 patients, 81.7%). A peduncu-
lated mass was found in 63 patients (67.6%), while the
other 30 patients (32.3%) had a sessile mass. Other cardiac
surgeries were performed in 19 patients (20.4%), with
mitral valve surgery being the most common procedure
(Table 1). Four patients underwent mitral valve surgery
due to the organic change of the mitral valve (rheumatic
mitral stenosis in 1 and degenerative mitral insufficiency
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in 3). Four patients had myxoma-related mitral valve le-
sions. Four patients had mitral annular enlargement and
one of them had a leaflet fibrotic change.
The most common symptom was dyspnea in 36 pa-
tients, 19 of whom had severe dyspnea greater than New
York Heart Association functional classification III.
Other cardiac or embolic symptoms included chest pain,
palpitation, syncope, and stroke. Constitutional symp-
toms, such as fever, cough, weight loss, and headache,
occurred in five patients, whereas 18 patients had an
intracardiac mass detected incidentally without any
symptoms (Table 2).
All myxomas were diagnosed by transthoracic echo-
cardiography. However, if tumors other than myx-
omas were suspected, we performed transesophageal
echocardiography, chest computed tomography, or
magnetic resonance imaging.
Sixty-five patients underwent elective surgery, whereas
28 patients with severe symptoms or embolic risk under-
went emergency surgery. Regarding elective surgery, pre-
operative coronary angiography was performed routinely
in all male patients over 40 years of age and postmeno-
pausal women. All surgeries were performed through me-
dian sternotomy. Routinely, the ascending aorta and both
caval veins were cannulated, and a cardioplegic solution
was infused in an antegrade or retrogade fashion. Retro-
grade cardioplegia infusion was used when aortic insuffi-
ciency was found on preoperative 2D echocardiography,
or the operation time was expected to take longer due to
combined operation like valve surgery. Surgery was per-
formed via a biatrial approach in 69 patients (74.2%),
transseptal approach with right atriotomy and septotomy
in 16 (17.2%), and left atriotomy only in eight patients
(8.6%), depending on the size and location of the mass
confirmed on preoperative 2D echocardiography.
Simple myxoma resection including the endocardium
and attached stalk without any need to repair was per-
formed in 17 patients, direct closure of the defect area was
performed in 47, and patch closure with autopericardium
or prosthetic material was performed in 29. If the expected
defect was too large to close directly, based on preoperative
2D echocardiography, autopericardium was harvested be-
fore pericardiotomy and fixed with glutaraldehyde for
5 min. If the defect was recognized as too large to close
directly, prosthetic material was used for closure; bovine
pericardium (Supple Peri-Guard®; Synovis Surgical Innova-
tions, St. Paul, MN) or a dacron patch (Bard® Sauvage®
Filamentous Knitted Polyester Fabric; Bard Peripheral Vas-
cular Inc., AZ) was used according to the preference of the
surgeon. Mean cardiopulmonary bypass time was 80.7 ±
39.0 min (range, 19–231 min), and mean aortic cross-
clamping time was 51.3 ± 27.5 min (range, 9–153 min).
Mean myxoma size based on the longest length was
4.73 ± 1.92 cm (range, 1.2–11.0 cm), and a giant myxoma
over 10 cm in length was found in two patients (10.0 ×
4.0 × 2.0 cm and 11.0 × 10.0 × 3.5 cm) (Fig. 1). One patient
was recommended surgical resection of a mass located on
the fossa ovalis measuring approximately 1.66 × 1.6 ×
1.0 cm. However, she refused the surgery and revisited
15 months later with severe dyspnea resulting from func-
tional mitral stenosis. Preoperative 2D echocardiography
revealed that the mass had grown to 7.7 × 3.38 × 1.0 cm
(Fig. 2). Surgical resection was performed successfully.
Long-term survival was assessed based on the National
Health Insurance database. Results are presented as
mean ± SD. Long-term cumulative survival was analyzed
using the Kaplan-Meier method. Analyses were
performed using PASW version 18.0 (IBM Corporation,
Armonk, NY, USA). This study was approved by the
Institutional Review Board of Chonnam National
University Hospital (IRB No. CNUH-2016-217), which
Table 1 Cardiac surgeries performed concurrently with
myxoma resection
Surgery n (%)




MVP + TVP 1 (1.1)
MVP +Maze procedure 1 (1.1)
MVR +Maze procedure 1 (1.1)
AVR +Maze procedure 1 (1.1)
PFO closure 1 (1.1)
RVOT release 1 (1.1)
VSD closure 1 (1.1)
Lung wedge resection 1 (1.1)
Abbreviations: AVR aortic valve replacement, CABG coronary artery bypass
grafting, MVP mitral valvuloplasty, MVR mitral valve replacement, PFO patent
foramen ovale, RVOT right ventricular outflow tract, TVP tricuspid valvuloplasty,
VSD ventricular septal defect
Table 2 Preoperative clinical symptoms and signs
Symptom/sign n (%)
Dyspnea 36 (38.7)







Weight loss 1 (1.1)
Nausea 1 (1.1)
Asymptomatic 18 (19.4)
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waived the requirement for informed patient consent
because of the retrospective nature of the study.
Results
The most common postoperative complications were
atrial fibrillation in four patients and wound infection in
3. Newly developed atrial fibrillation occurred after a
biatrial or transseptal approach in two patients each (p
= 0.136), with no conduction disturbance postopera-
tively. Other complications included low cardiac output
syndrome, complete atrioventricular block, cerebral
hemorrhage, hoarseness, pneumonia, and acute cholangitis.
Fig. 1 Images of a giant myxoma. a The resected myxoma is huge. b The resected myxoma has a broad base of approximately 4 cm in diameter
Fig. 2 Images of a rapidly growing myxoma. a A small myxoma is attached to the left atrial side of the fossa ovalis. b An enlarged myxoma
passes in and out of the mitral valve according to the cardiac cycle. c The resected myxoma is sessile and has a narrow base
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In-hospital mortality occurred in three patients (3.2%) due
to postoperative pneumonia, low cardiac output syndrome
(the patient had a ventricular septal defect with a myxoma
in the left ventricle), or metabolic acidosis and dilutional
coagulopathy after massive transfusion caused by intraoper-
ative coronary sinus rupture.
Mean follow-up duration was 9.9 ± 7.8 years (range,
0–29 years), and 12 of 93 patients became ineligible for
the National Health Insurance; these 12 patients were
regarded as dead because change in nationality was not
identified during this period. The 5-, 10-, and 30-year
survival rates were 92.9, 87.2 and 75.5%, respectively
(Fig. 3). Myxoma recurred in two patients (2.1%) during
the follow-up period. One patient with multiple myx-
omas in the LA, right atrium, and right ventricle under-
went a reoperation 79 months after the primary
operation. The recurred masses were located on the LA
roof, right atrial septum, and trabecula of the right ven-
tricle. All masses were widely resected, the septal defect
was reconstructed using a Dacron patch, and plication
was performed for LA roof repair. The other patient
experienced cerebral infarction 20 months after the pri-
mary surgery, and 2D echocardiography revealed a mass
on the previously resected margin; myxoma could not
be ruled out completely. The patient refused a reopera-
tion, and the mass did not grow during the follow-up
period. These recurred patients underwent direct closure
of the defect after tumor removal. No recurred tumor was
evident in patients with simple myxoma resection or
patch closure of the defect. However, this was not statisti-
cally significant because there were few recurred cases.
Discussion
Myxoma is the most common primary cardiac tumor,
which frequently occurs in middle age and is more com-
mon in women than in men [2–5]. In our data, the mean
age of the patients was 54.7 years at the time of surgery,
and 86% were aged over 40 years. In addition, myxoma
was 2 times more common in women than in men.
Myxomas vary in size, but the growth rate is difficult
to document because they are usually removed after
diagnosis [6–9]. However, in our study, the one patient
who underwent surgery 15 months after initial diagnosis
showed a rapid growth rate of 0.41 cm/month.
Although operative mortality is reported to be within
5%, the rate is increased with myxoma occurring in the
ventricle [3, 5, 10, 11]. In our data, in-hospital mortality
occurred in three patients. One patient died from low
cardiac output syndrome after extensive resection of the
left ventricle, while the other two patients died from
pneumonia or coronary sinus rupture, which may occur
after cardiac surgery. Pneumonia after cardiac surgery is
Fig. 3 Long-term cumulative survival after myxoma resection
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one of the most common causes of postoperative mor-
tality, and coronary sinus rupture during retrograde car-
dioplegia infusion is also a possible complication during
cardiac surgery. These complications may occur due to
the nature of cardiac surgery rather than myxoma itself.
Although myxoma resection is relatively simple com-
pared with other cardiac surgeries, it does require car-
diopulmonary bypass during cardiac arrest. Therefore,
postoperative complications may occur as in other more
complex cardiac surgeries, and should be recognized.
Regarding the surgical approach, a biatrial approach is
helpful to determine the correct resection margin by
confirming the tumor pedicle under direct visualization,
to minimize manipulation of the tumor, to find hidden
myxomas by inspection of all heart chambers, and to se-
cure the septal defect after resection of a tumor located
on the atrial septum [12]. On the other hand, a transsep-
tal approach through right atriotomy may provide ad-
equate mass exposure and, as a result, low recurrence
and easy repair of a single incision on the right atrium
[13]. However, if the myxoma is sessile, has a broad base,
and is attached to the atrial septum, a biatrial approach,
rather than a transseptal approach, may reduce the risk
of injury and tumor emboli. Even though a transseptal
approach is simpler than a biatrial approach, it is only
useful when the myxoma is pedunculated and has a nar-
row stalk. We primarily used biatrial incisions, but, a
transseptal approach or left atriotomy only was used for
resection of small myxomas confirmed on preoperative
2D echocardiography. Our institution does not have a
guideline regarding the incision site as it relates to
tumor size. However, if the largest tumor is less than 2
~ 3 cm in size, wherein the tumor fully can be removed
through a transseptal incision without breaking, the base
of the stalk is narrow, and the motion of the tumor is
active according to the heart beat on 2D echocardiog-
raphy, we use a transseptal approach. In all other cases,
a left atriotomy should be performed first. The position
and shape of the tumor is evaluated, and, if the tumor
can be removed without manipulation, it is removed
without an additional incision. If the stalk is short or of
a sessile form, we perform an additional right atriotomy
to secure the resection margin. Because all tumors can
be detected on preoperative transthoracic echocardiog-
raphy due to advances in imaging techniques, and add-
itional intracardiac evaluation is performed during
surgery using transesophageal echocardiography, espe-
cially when left atriotomy only is performed, additional
cardiac incisions for evaluation of all cardiac chambers
may not be necessary.
The recurrence rate after myxoma resection has been
reported to be less than 5% [3–5, 12]. In our data, two
patients (2.1%) had recurrence. One patient had multiple
myxomas and underwent a reoperation. The other
patient was suspected to have recurrence on the atrial
septum, but it was not confirmed histologically. Because
we could not rule out myxoma completely, we regarded
it as recurrence on the previously resected margin. Myx-
oma recurrence is caused by incomplete resection or
tumor seeding during mass manipulation [14]. Our two
cases of recurrence were thought to be caused by in-
complete primary resection because they were located
on the resection margin. Therefore, some authors insist
on wide resection to prevent recurrence following in-
complete resection [15]. However, other reports claim
that simple tumor resection is sufficient because of the
low recurrence rate [4, 16]. Our recurred patients
underwent full-layer resection including the stalk and
primary closure, and no patient who underwent only
simple myxoma resection without defect repair was
recurred. Therefore, it is thought that all myxoma pa-
tients are not necessary taken full-layer resection. How-
ever, in cases of myxoma occurring at a relatively young
age, with ventricular origin, family history, Carney com-
plex, or multiple myxomas, full-layer wide resection is
recommended because of the increased recurrence rate
[3, 5, 12, 17].
Our study has several limitations. First, this was a
retrospective study. However, this study design was inev-
itable because cardiac tumors are extremely rare and
early surgical resection is the treatment of choice. Sec-
ond, we estimated mortality as total death without con-
sidering cardiac or sudden death separately. Although
this does not reflect disease-related mortality specifically,
it is thought that total death lowers selection bias.
Conclusions
Clinical outcomes of myxoma resection are acceptable,
but complications associated with cardiopulmonary by-
pass or cardiac arrest should be recognized. Although
recurrence is low and is not affected by surgical method,
wide resection is generally recommended in patients
with increased likelihood of recurrence.
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